Nuvalent (NUVL)
(Delayed Data from NSDQ)
$77.52 USD
-2.02 (-2.54%)
Updated Sep 25, 2025 04:00 PM ET
After-Market: $77.50 -0.02 (-0.03%) 7:58 PM ET
3-Hold of 5 3
C Value F Growth A Momentum D VGM
Fundamental Charts
About Dividend Yield (TTM)
Nuvalent, Inc.'s dividend yield currently sits at 0%, which is in-line with the Medical - Biomedical and Genetics industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
NUVL 77.52 -2.02(-2.54%)
Will NUVL be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for NUVL based on the 1-3 month trading system that more than doubles the S&P 500.
Other News for NUVL
Is NUVL consolidating before a move? Bollinger Band Squeeze shows up after sinking 1.9%
NUVL forms 20 Day Moving Average Support on September 23
Barclays Keeps Their Buy Rating on Nuvalent (NUVL)
COMMODORE CAPITAL LP Acquires 1,225,000 Shares in LB Pharmaceuticals Inc
Crossed Above 20 Day Moving Average appears for NUVL after 2.91% move